- Home
- PHAT vs TOI Comparison
PHAT vs TOI Comparison
Compare PHAT & TOI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PHAT
- TOI
- Stock Information
- Founded
- PHAT 2018
- TOI 2007
- Country
- PHAT United States
- TOI United States
- Employees
- PHAT N/A
- TOI N/A
- Industry
- PHAT Biotechnology: Pharmaceutical Preparations
- TOI Medical/Nursing Services
- Sector
- PHAT Health Care
- TOI Health Care
- Exchange
- PHAT Nasdaq
- TOI Nasdaq
- Market Cap
- PHAT 289.0M
- TOI 266.8M
- IPO Year
- PHAT 2019
- TOI N/A
- Fundamental
- Price
- PHAT $8.92
- TOI $2.78
- Analyst Decision
- PHAT Strong Buy
- TOI
- Analyst Count
- PHAT 4
- TOI 0
- Target Price
- PHAT $16.25
- TOI N/A
- AVG Volume (30 Days)
- PHAT 4.4M
- TOI 2.2M
- Earning Date
- PHAT 05-01-2025
- TOI 05-14-2025
- Dividend Yield
- PHAT N/A
- TOI N/A
- EPS Growth
- PHAT N/A
- TOI N/A
- EPS
- PHAT N/A
- TOI N/A
- Revenue
- PHAT $81,859,000.00
- TOI $403,152,000.00
- Revenue This Year
- PHAT $195.45
- TOI $23.95
- Revenue Next Year
- PHAT $106.76
- TOI N/A
- P/E Ratio
- PHAT N/A
- TOI N/A
- Revenue Growth
- PHAT 3055.70
- TOI 17.64
- 52 Week Low
- PHAT $2.21
- TOI $0.13
- 52 Week High
- PHAT $19.71
- TOI $3.50
- Technical
- Relative Strength Index (RSI)
- PHAT 82.93
- TOI 48.63
- Support Level
- PHAT $4.47
- TOI $2.87
- Resistance Level
- PHAT $4.99
- TOI $3.27
- Average True Range (ATR)
- PHAT 0.89
- TOI 0.33
- MACD
- PHAT 0.39
- TOI -0.06
- Stochastic Oscillator
- PHAT 60.60
- TOI 33.18
About PHAT Phathom Pharmaceuticals Inc.
Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.
About TOI The Oncology Institute Inc.
The Oncology Institute Inc offers oncology services committed to improving cancer prevention, diagnosis, treatment, research, and education. The company provides services including infusion centres. In-house dispensary, Outpatient blood transfusion, Outpatient stem cell transplant, financial counseling, clinical trials, comprehensive lab testing, and end-of-life counseling. The business operates in three operating segments dispensary, patients services and clinical trials and others. Key revenue is earned from providing patient services. Majority of revenue is from patients services.